Tagged with VAT

Pharma Yves Bur reveals how the motivation behind his political engagement has been to raise awareness around the importance of improving the social security system. Bur also explains why having a real public health policy is another way of combatting the increase in health spending, and how France needs to reach…

Pharma Centre International de Développement Pharmaceutique (CIDP) has pioneered cosmetic and pharmaceutical Research & Development in Mauritius, and is Mauritius’ flagship success story in the sector. Founded over 10 years ago, CIDP is an international CRO (Contract Research Organisation). As an entrepreneur and a pioneer, which opportunities did you see in Mauritius that…

Holland Pharming Group CEO Sijmen de Vries discusses the advantages of his company’s transgenic platform for recombinant protein production, the commercial progress of their lead product Ruconest, and the company’s plans for developing new applications through the platform, including a partnership with the SinoPharm subsidiary SIPI. From a production point of…

Holland A serial entrepreneur, Henk Viëtor founded the Drug Discovery Factory as an active venture fund focused on translating life science research into medical innovation. He discusses his perspective on the Dutch startup environment, and makes his case for how the country should proceed if it is serious about supporting the…

Holland Pivot Park in Oss, the Netherlands, aims at becoming an inspiring campus for open innovation in life sciences. The CEO discusses the unique assets the park offers to companies and calls for an increased collaboration among private industry, academia, and government to enhance the country’s global competitiveness. You took over…

Chiesi Chiesi is preparing to market two first in class products: the first approved stem cell treatment in Europe, and the first approved gene-therapy, developed in the Netherlands by partner UniQure. General Manager Nether Maurits Huigen discusses the challenges his affiliate is facing to bringing these pioneering products to market, along…

Thailand Pfizer is now the number one pharmaceuticals company in Thailand. We spoke to Christian Malherbe, Country Lead for IndoChina, which includes Myanmar, Laos, and Cambodia, about how he is making the management structure flatter and continuing to bring new medicines to the region.   In the future, we see our…

healthcare In the past, the Moroccan pharmaceutical sector primarily served local needs. Now it is ramping up its research and development capabilities, looking outwards to global markets, developing partnerships with other African countries, and beginning to think about social programs such as public access to healthcare. “[Morocco’s] success grew from a…

strategic levels Umut Gökalp, managing director of Japan’s Sysmex in Turkey – a company specialising in in-vitro diagnostics – evaluates their approach to developing business opportunities in the Turkish medical device sector. He also describes how the company’s new reagent facility in Germany will help bolster it domestically and regionally. Can you tell us…

investment The new government of Mauritius has chosen pharmaceuticals, healthcare and life sciences as priorities for the country’s innovation economy. Pharmaboardroom spoke with Ameenah Gurib Fakim, president of the Republic of Mauritius, who outlined her country’s strengths, and the challenge of replacing the country’s conventional “sun and sand” image with life sciences. Mauritius’ successful growth…

Boehringer Ingelheim Sirilak Suteekul explains the organization’s success in Thailand over the last couple of years, Thailand’s untapped potential as a regional center in Southeast Asia and how innovation adds value to society. As managing director of the organization for nearly two years, what have been your major challenges and accomplishments since…

basic research The Thailand Center of Excellence for Life Sciences (TCELS) CEO shares his ambitions to make Thailand a place for innovative business practices, the organization’s role in promoting and supporting research and the unique role TCELS plays in creating a regulatory frameworks for the life sciences industry. What special experiences led…